Shengjie Jin
Yangzhou, 225001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Effects of laparoscopic splenectomy and azygoportal disconnection on immune remodeling in cirrhosis patients with portal hypertension bleeding: a 1-year prospective study.
Journal: Surgical endoscopy
Published: May 09, 2026
Cuproptosis in hepatocellular carcinoma: bridging copper homeostasis with therapeutic horizons.
Journal: Molecular biology reports
Published: March 16, 2026
FBXO32 ubiquitination of SUFU promotes progression and lenvatinib resistance in hepatocellular carcinoma via hedgehog signaling.
Journal: Medical oncology (Northwood, London, England)
Published: December 16, 2024
Comparison of Apixaban and Aspirin in Preventing Portal Vein Thrombosis after Laparoscopic Splenectomy for Cirrhotic Hypersplenism.
Journal: Thrombosis and haemostasis
Published: December 13, 2024
Degradation of PARP1 by MARCHF3 in tumor cells triggers cCAS-STING activation in dendritic cells to regulate antitumor immunity in hepatocellular carcinoma.
Journal: Journal for immunotherapy of cancer
Published: October 26, 2024
Integrative Analysis the Role of ENG as a Metabolic and Macrophage-Related Gene in Hepatocellular Carcinoma.
Journal: Biochemical genetics
Published: October 05, 2024
Intratumoral microbiota: an emerging force in diagnosing and treating hepatocellular carcinoma.
Journal: Medical oncology (Northwood, London, England)
Published: September 12, 2024
TRIM29 reverses lenvatinib resistance in liver cancer cells by ubiquitinating and degrading YBX1 to inhibit the PI3K/AKT pathway.
Journal: Translational oncology
Published: August 04, 2024
Effects of Indocyanine Green (ICG) Imaging-Assisted Cholecystectomy on Intraoperative and Postoperative Complications: A meta-Analysis.
Journal: Surgical innovation
Published: April 24, 2024
Last Updated: 09/26/2026